Editorial |
From the Departments of Pharmacology and Cell Biophysics (A.Y.), University of Cincinnati College of Medicine, Cincinnati, Ohio; Departments of Medicine and Physiology (T.J.K.), University of Wisconsin, Madison, Wis.
Correspondence to Dr Atsuko Yatani, Department of Pharmacology and Cell Biophysics, University of Cincinnati College of Medicine, Cincinnati, OH 45267-0575. E-mail yatania{at}uc.edu
Key Words: L-type Ca2+ channels
1 subunit hypoxia patch clamp mutagenesis
| Introduction |
|---|
|
|
|---|
1 subunit and auxiliary subunits including
ß,
2/
, and
.1 Multiple
genes are known to encode a variety of isoforms for each subunit. Given
their prominent role in the regulation of cellular processes, it is not
surprising that these channels are subject to extensive regulation. A
myriad of neurohumoral factors can modulate Ca2+
channel function via a variety of transmembrane receptors and signaling
cascades.1 The best-studied example is ß-adrenergic
receptormediated stimulation of cardiac L-type
Ca2+ channels by the cAMP/cAMP-dependent protein
kinase pathway. Most of these regulatory pathways are thought to act by
altering the phosphorylation status of the channel,
although the molecular details of these putative
phosphorylation events have not been fully resolved.
But the story does not end with these channels responding only to
traditional neurohormones. Recent studies have also revealed that the
L-type Ca2+ channel can be modulated by
hypoxia both in native vascular smooth muscle
cells,2 carotid body chemoreceptor cells,3
and in recombinant systems.4 How can acute hypoxia regulate channel activity? Changes in cellular metabolism resulting from hypoxia or ischemia can modulate channel function by changing the phosphorylation status of the channel. However, there are many other manners in which channels may respond more directly and rapidly to changes in O2 levels.5 For example, a channel could contain an O2 sensing moiety such as a heme group or be closely associated with a protein that contains such an O2 sensor module. Alternatively, a metabolite of O2 may be sensed, such as changes in reactive oxygen species or redox state. In the case of voltage-gated K+ channels in pulmonary smooth muscle cells, investigators have provided evidence that changes in the local redox environment may be responsible for hypoxic inhibition of these channels.6 The idea is that changes in the ratio of reduced/oxidized redox couples such as glutathione (GSH/GSSG) can reduce or oxidize the channels or associated proteins altering their function.
What is known about redox modulation of L-type
Ca2+ channels? In 1995, Chiamvimonvat et
al7 demonstrated that Ca2+ current
(ICa) expressed by recombinant
1 subunit of L-type Ca2+
channel from rabbit lung was inhibited by 2,2'-dithiodipyridine (DTDP,
a specific lipophilic oxidizer of sulfhydryl groups) and that the
effect was readily reversed by 1,4-dithiothreitol (DTT, an agent that
reduces disulfide bonds). Similar results were obtained by using the
hydrophilic sulfhydryloxidizing agent, thimerosal. DTT alone had no
effect on ICa. The effects were
Ca2+ channel-specific: DTDP induced no changes in
expressed human cardiac Na+ currents. This was
the first study that demonstrated that the pore-forming
1 subunit of the L-type
Ca2+ channel contains functionally important
"free" sulfhydryl groups that may be sensitive to the oxidation
state of the cell. Redox modulation of L-type
Ca2+ channels by oxidizing and reducing agents
acting at the thiol group in the channel has also been demonstrated in
native channels in ferret ventricular
myocytes,8 although the details of modulation
differ.
Are hypoxic regulation and thiol-specific redox modulation of L-type
channels related? Recent studies by Fearon et al9 on human
1C recombinant L-type
Ca2+ channels expressed in HEK cells confirmed
the previous findings in that the oxidizing agents thimerosal and
p-chloromercuribensen sulfonic acid (PCMB) caused inhibition
of Ca2+ channel currents, and the reducing agent
DTT reversed the inhibitory actions of thimerosal and PCMB.
The Ca2+ channel currents were also inhibited by
pretreatment with the positively charged methanethiosulphonate compound
(MTSEA), which can oxidize available cysteines. The effects of the two
sulfhydryl-modifying agents PCMB and MTSEA were additive, suggesting
that the distinct thiol groups were modulated by these two agents. This
study then demonstrated that hypoxic inhibition of
Ca2+ channel currents was unaffected by
pretreatment of cells with MTSEA but was fully prevented by treatment
with PCMB, suggesting that distinct cysteine residues on the
1C subunit are sensitive to PCMB treatment
(but not those sensitive to MTSEA treatment) are involved in hypoxic
inhibition of the channel.
In this issue of Circulation Research, Fearon et
al10 take the next step to link
O2-sensing with redox modulation of channel
activity by identifying the structural region involved in
hypoxia-mediated Ca2+ channel regulation.
In this study, the authors examined the effects of hypoxia on
three naturally occurring splice variants of the human
1C subunit (hHT, rHT, and fHT) of the L-type
Ca2+ channel that differ only in the COOH-tail
region.11 Although the initial characterization of these
three splice variants showed no clear differences in the properties of
the expressed currents,11 the study by Fearon et
al10 remarkably demonstrates that hypoxia inhibits
ICa in cells expressing the hHT splice variant
and not the rHT or the fHT splice variants. This result suggests that a
71-amino acid insert present in hHT in the COOH-tail region of the
channel confers oxygen sensitivity. Using mutagenesis, this
interpretation is substantiated by data demonstrating both loss of
function and gain of function. The results further identify a 39-amino
acid region in the COOH terminus that is essential for oxygen sensing.
This work represents the first structural clue to help unravel
the mechanisms of hypoxic regulation of ion channels.
This finding opens the door to a wealth of experiments to further
dissect out the molecular details of hypoxia regulation of the
channels. First, we still do not know if it is the
1C subunit itself that is directly modified or
whether a closely associated protein acts as the
O2 sensor and has its sulfhydryl group(s)
modified. An obvious step toward addressing this question would be to
test the effect of site-directed mutagenesis of the three cysteine
residues present in the identified 39-amino acid essential segment.
If this property could be localized to a particular amino acid residue,
it would strongly support the hypothesis that the
1C subunit itself is the direct target. In
addition, we do not know what redox couple may be responsible during
hypoxia for potentially modifying the channel. It may be
possible that this represents a site for redox reaction on
thiol groups by NO.8 12 The results also add to the
mystique of the COOH-tail of the
1C channel,
which has been associated with
Ca2+/calmodulin-dependent
inactivation/facilitation,13 binding of
sorcin,14 and protein kinase A regulation of the
channel.15 To add to the mystery, the portion of the
COOH-tail that contains the hHT splice variation may be truncated in
neuronal and cardiac tissues, although recently this truncated fragment
of the C-tail has been suggested to remain associated with the channel
complex.16 How the COOH-terminus of the channel is
specifically targeted by hypoxia and how this alters channel
behavior represent important questions for future research.
The distinct functional properties of these splice variants of the
1C subunit have likely been put to good use by
nature. For example, the differential oxygen sensitivity of L-type
Ca2+ channels in conduit compared with resistance
pulmonary artery smooth muscle cells could easily be explained
by alternative splice variants being expressed in these
cells.17 In general, vascular smooth muscle cells that
respond to hypoxia by relaxing may express the hHT splice
variant and display associated Ca2+ channel
inhibition, whereas those smooth muscle cells that constrict in
response to hypoxia, ie, pulmonary resistance vessels,
may not express hHT. Additionally, differences in splice variants could
be important in a variety of cardiovascular,
neurological, and endocrine diseases. For example, reducing
Ca2+ influx in the setting of myocardial
ischemia could be protective, suggesting that these
1C splice variants could be important in
ischemic heart disease. Will this mechanism of channel
regulation be able to be put to use in new therapies? Clearly, further
research is needed to understand the role of these
1C splice variants and hypoxia in
normal physiology and disease, and the results presented by
Fearon et al,10 open the door to exciting new
advances.
| Footnotes |
|---|
| References |
|---|
|
|
|---|
1C subunit of the human cardiac L-type
Ca2+ channel. J Physiol (Lond). 1997;500:551556.
1C subunits by redox agents and
hypoxia. J Physiol (Lond). 1999;514:629637.
1-subunit. Am J Physiol. 1997;272(3 pt
2):H13721381.
1 subunit of
the cardiac L-type calcium channel by adenosine 3',5'-cyclic
monophosphate-dependent protein kinase. Biochemistry. 1996;35:1039210402.[Medline]
[Order article via Infotrieve]
1C subunit of L-type calcium channels
and the role of a proline-rich domain in membrane tethering of
proteolytic fragments. J Biol Chem. 2000;275:85568563.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2000 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |